Louisiana 2018 Regular Session

Louisiana House Bill HB690

Introduced
3/2/18  
Introduced
3/2/18  
Refer
3/2/18  
Refer
3/12/18  
Report Pass
3/28/18  
Report Pass
3/28/18  
Engrossed
4/9/18  
Engrossed
4/9/18  
Refer
4/10/18  
Refer
4/10/18  
Report Pass
5/2/18  
Report Pass
5/2/18  
Enrolled
5/16/18  
Enrolled
5/16/18  
Chaptered
5/23/18  
Chaptered
5/23/18  

Caption

Provides for coverage for subsequent preventive tests for certain individuals diagnosed with breast cancer

Impact

The enactment of HB 690 will likely have a significant impact on state health laws, particularly those governing insurance coverage and medical assistance programs. The bill specifies that preventive screenings are not only required under private health insurance plans but also designated as Medicaid-covered services. This dual coverage is expected to extend necessary healthcare services to individuals who may otherwise struggle to afford regular screenings, thus promoting a more comprehensive approach to post-cancer care across Louisiana.

Summary

House Bill 690 is designed to mandate health insurance coverage for preventive cancer screening services for individuals who have undergone bilateral mastectomy due to breast cancer. The bill stipulates that any health benefit plan issued in Louisiana must provide coverage for annual preventive screenings for qualified individuals who are cancer-free after completing treatment. This legislative move aims to ensure that breast cancer survivors have access to necessary follow-up care to detect new primary cancers early, thereby improving long-term survival rates.

Sentiment

The general sentiment surrounding HB 690 has been largely positive, particularly among advocacy groups and healthcare providers focused on women's health. Proponents argue that the bill is a crucial step in providing equitable healthcare options for breast cancer survivors and filling a critical gap in the current healthcare landscape. They emphasize the importance of proactive health measures and preventive care in improving the quality of life for cancer survivors.

Contention

Notable points of contention surrounding the bill are not explicitly documented in the discussions, but potential concerns could arise regarding the financial implications for insurance providers and the logistics of implementing mandatory screenings. Stakeholders may worry about the administrative burden of communicating new coverage details to enrollees and ensuring compliance with the new regulations. However, the bill primarily aims to address health equity and provide much-needed support for individuals affected by breast cancer.

Companion Bills

No companion bills found.

Previously Filed As

LA HB689

Provides for coverage for fertility preservation for individuals diagnosed with cancer (EG INCREASE GF EX See Note)

LA HB272

Provides relative to health insurance coverage for breast cancer screening and diagnosis

LA HB347

Provides relative to health insurance coverage for breast cancer screening and treatment (EN INCREASE SG EX See Note)

LA H0773

Coverage for Diagnostic and Supplemental Breast Examinations

LA HB345

Provides for coverage for breast and ovarian cancer susceptibility screening (EN NO IMPACT See Note)

LA SB2858

Health benefit plans; set provisions related to diagnostic breast exams and individualized investigational drugs.

LA S0158

Coverage for Diagnostic and Supplemental Breast Examinations

LA HB1296

Relative to insurance coverage for diagnostic and supplemental breast examinations.

LA SB154

Provides for health insurance coverage of genetic testing for critically ill infants with no diagnosis. (1/1/23)

LA HB1079

To Mandate Coverage For Genetic Testing For An Inherited Gene Mutation For Certain Individuals; And To Mandate Coverage For Evidence-based Cancer Imaging For Certain Individuals.

Similar Bills

No similar bills found.